News|Articles|April 1, 2010

Formulary Digital Edition April 2010

Reducing cardiovascular risk is patients with type 2 diabetes: management of dyslipidemia; Focus on naproxicond; Drug Watch: Agents in late-stage development for the treatment of hepatitis C

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.


Latest CME